CDKN2A and neoplasm: Interestingly, the tumour with the highest degree of CDK4 phosphorylation (E3, a patient who died 2 months after diagnosis) presented also an elevated CDKN2A mRNA expression (Fig. 6E; Table S8B), but its p16 staining was weak (Fig. 6D; Table S8A).